Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer.
Saved in:
| Title: | Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer. |
|---|---|
| Authors: | Weisman M; Department of Radiation Oncology, Indiana University School of Medicine., Durm G; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine., Shields MD; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine., Hanna NH; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine., Althouse S; Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana., Lautenschlaeger T; Department of Radiation Oncology, Indiana University School of Medicine. Electronic address: timlaut@iu.edu. |
| Source: | International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2025 Mar 01; Vol. 121 (3), pp. 720-727. Date of Electronic Publication: 2024 Oct 26. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39490906 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Weisman+M%22">Weisman M</searchLink>; Department of Radiation Oncology, Indiana University School of Medicine.<br /><searchLink fieldCode="AU" term="%22Durm+G%22">Durm G</searchLink>; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine.<br /><searchLink fieldCode="AU" term="%22Shields+MD%22">Shields MD</searchLink>; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine.<br /><searchLink fieldCode="AU" term="%22Hanna+NH%22">Hanna NH</searchLink>; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine.<br /><searchLink fieldCode="AU" term="%22Althouse+S%22">Althouse S</searchLink>; Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana.<br /><searchLink fieldCode="AU" term="%22Lautenschlaeger+T%22">Lautenschlaeger T</searchLink>; Department of Radiation Oncology, Indiana University School of Medicine. Electronic address: timlaut@iu.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603616%22">International journal of radiation oncology, biology, physics</searchLink> [Int J Radiat Oncol Biol Phys] 2025 Mar 01; Vol. 121 (3), pp. 720-727. <i>Date of Electronic Publication: </i>2024 Oct 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2C+Inc%22">Elsevier, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603616 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-355X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203603016%22">03603016 </searchLink><i>NLM ISO Abbreviation: </i>Int J Radiat Oncol Biol Phys <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39490906 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ijrobp.2024.09.050 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 720 Titles: – TitleFull: Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Weisman M – PersonEntity: Name: NameFull: Durm G – PersonEntity: Name: NameFull: Shields MD – PersonEntity: Name: NameFull: Hanna NH – PersonEntity: Name: NameFull: Althouse S – PersonEntity: Name: NameFull: Lautenschlaeger T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2025 Mar 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1879-355X Numbering: – Type: volume Value: 121 – Type: issue Value: 3 Titles: – TitleFull: International journal of radiation oncology, biology, physics Type: main |
| ResultId | 1 |
